Are you John T. Couvillion, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileBased in Baton Rouge, LA, John T. Couvillion, M.D. is listed in the NPI registry under ophthalmology. John graduated from Tulane University School of Medicine in 1993. John is also listed as specializing in specialist. Medicare claims data shows John provided 16,243 services to 2,660 patients. The services billed most often include injection, faricimab-svoa, 0.1 mg, injection, ranibizumab, 0.1 mg, and injection, avacincaptad pegol, 0.1 mg. NPI 1497762207 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
10202 JEFFERSON HWY STE D
Baton Rouge, LA 70809
Within Ophthalmology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Eye injury and cancer
Inflammation, neurologic, and orbit
Most searched conditions
Cornea and external eye
Eyelid and tear drainage
Refractive and focusing
Retina and vitreous
Eye injuries
Retina & vitreous
Cataract and lens
Cornea and refractive
Emergency and minor
Examination and imaging
Eyelid, tear duct, and muscle
Glaucoma
Retina
Most searched procedures
Corneal procedures
Eye diagnostics
Eye injuries
Eyelid surgery
Laser eye surgery
Laser procedures
Laser vision correction
Refractive surgery
Tear duct & Orbit
16,243 services · 2,660 patients · 16 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Injection of drug into eye | Procedure | 67028 |
1,095 | More often than most peers in Ophthalmology |
| Destruction of growth of retina using a laser | Procedure | 67210 |
31 | As often as other peers in Ophthalmology |
| Destruction of leaking blood vessels of retina using laser | Procedure | 67228 |
22 | As often as other peers in Ophthalmology |
| Imaging of retina | Treatment | 92134 |
896 | More often than most peers in Ophthalmology |
| Exam of retinal blood vessels using a special camera after injection of a dye | Treatment | 92235 |
348 | More than most peers in Ophthalmology |
| Photography of the retina | Treatment | 92250 |
333 | More often than most peers in Ophthalmology |
| Injection, faricimab-svoa, 0.1 mg | Drug given | J2777 |
6,121 | Less often than most peers in Ophthalmology |
| Injection, ranibizumab, 0.1 mg | Drug given | J2778 |
3,844 | More than most peers in Ophthalmology |
| Injection, avacincaptad pegol, 0.1 mg | Drug given | J2782 |
1,681 | As often as other peers in Ophthalmology |
| Unclassified drugs | Drug given | J3490 |
15 | Less often than most peers in Ophthalmology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
John T. Couvillion is an eye doctor in Baton Rouge, LA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Ophthalmology”.
NPI registry
John T. Couvillion is listed at 10202 Jefferson Hwy Ste D, Baton Rouge, LA 70809. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (225) 768-8833. Contact the office directly to confirm availability and scheduling.
NPI registry
John T. Couvillion's National Provider Identifier is 1497762207. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
John T. Couvillion attended Tulane University School of Medicine, graduating in 1993. This comes from the CMS National Downloadable File.
CMS public data
John T. Couvillion has 33 years experience. Calculated from a graduation year of 1993, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, John T. Couvillion performs procedures including injection of drug into eye, destruction of growth of retina using a laser and destruction of leaking blood vessels of retina using laser; provides treatments such as imaging of retina and exam of retinal blood vessels using a special camera after injection of a dye, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by John T. Couvillion. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.